§ EQUITY
USD

DRUG

BRIGHT MINDS BIOSCIENCES INC
USD
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
70 increased/new, 18 decreased/exited (13F)
AC 13F Analysis
ANALYST
6 buy, 1 hold, 0 sell
Finnhub
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
JANUS HENDERSON GROUP PLC1.3Mn/a+11%
Vivo Capital, LLC1.1Mn/a+122%
Cormorant Asset Management, LP1.1M3.9%±0%
BlackRock, Inc.622K0.0%+58%
BRAIDWELL LP540K1.3%+66%
ADAGE CAPITAL PARTNERS GP, L.L.C.496K0.1%+25%
◇ AC INTELLIGENCE

Top institutional owners for DRUG as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER65.5% · 60 holders
QUALITY / COMPOUNDER21.8% · 5 holders
PASSIVE / INDEX6.2% · 7 holders
DEALER / BANK3.5% · 14 holders
TACTICAL / MACRO2.9% · 2 holders
ACTIVIST0.1% · 1 holder
INCOME / DEFENSIVE0.1% · 4 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for DRUG in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention DRUG yet.